Evaluating systemic thrombolysis for acute portal vein thrombosis in cirrhotic patients
The prevalence of Portal Vein Thrombosis (PVT) varies significantly at different stages of liver disease: 10% in compensated patients, 17% ...
Tag: Heparin
UNIGE's synthetic anticoagulant provides reliable alternative to heparin
Anticoagulant treatments are crucial for managing many conditions, such as heart disease, stroke and venous thrombosis. Current options, however, carry ...
Breakthrough antibody therapy targets Alzheimer's risk gene, offers hope for effective treatment
In a recent article published in the Journal of Alzheimer’s & Dementia, researchers introduced and characterized a novel platform based ...
Cost-effectiveness analysis of four interventions for treatment of cancer-associated thrombosis
A cost-effectiveness analysis comparing direct oral anticoagulants (DOACs) to low-molecular-weight heparin (LMWH) found that DOACs are both more medically effective ...
Direct oral anticoagulants more effective and cost-effective for treating cancer-associated thrombosis
Research conducted by UC Davis Comprehensive Cancer Center and the University of Cincinnati shows that direct oral anti-coagulant (DOAC) drugs ...
Study suggests anti-PF4 antibodies may play a role in the severe multiorgan disease manifestations of COVID-19
In a recent study published in PNAS, researchers investigated the association between the increased levels of anti-platelet factor 4 (PF4) ...
Hospitalized COVID-19 patients with high blood viscosity have greater risk of death
Study Title: "Association of Blood Viscosity with Mortality among Patients Hospitalized with COVID-19" Journal: Journal of the American College of ...
